RecruitingNot ApplicableNCT05673915

Study of Transcranial Direct Current Stimulation to Treat Epilepsy

Pilot Study of Transcranial Direct Current Stimulation (tDCS) to Treat Epilepsy

Sponsor

Mayo Clinic

Enrollment

30 participants

Start Date

Apr 12, 2023

Study Type

INTERVENTIONAL

Conditions

Focal Epilepsy Generalized Onset Epilepsy Sleep-related Epileptic Encephalopathy

Summary

The purpose of this research is to see to what extent electrical stimulation applied to the scalp (transcranial direct current stimulation or tDCS) can reduce the number and intensity of epileptic seizures.

Eligibility

Min Age: 6 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called ActivaDose II 0.1 mA transcranial direct current stimulation (tDCS) and a medical device called ActivaDose II 2.0 mA transcranial direct current stimulation (tDCS) for people with focal epilepsy, generalized onset epilepsy, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 6 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEActivaDose II 0.1 mA transcranial direct current stimulation (tDCS)

Stimulation setting 0.1 mA daily for a 2-month period. Each daily treatment will last for approximately 30 minutes.

DEVICEActivaDose II 2.0 mA transcranial direct current stimulation (tDCS)

Stimulation setting 2.0 mA daily for a 2-month period. A Each daily treatment will last for approximately 30 minutes.

Locations(1)

Mayo Clinic Minnesota

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05673915

Related Trials

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

NCT075638814 locations

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

NCT075941195 locations

High-density Flexible μECoG for Epilepsy Surgery - A Single-Arm ECT

NCT076568571 location

Spatial Scene Recognition Memory in Epilepsy Surgery

NCT075801832 locations

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

NCT06132893124 locations